The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(+/-)-(4-((2S,3S)-2-(Benzo[d][1,3]dioxol-5-yl)-3-(4-fluorophenyl)-azetidin-1-yl)piperidin-1-yl)(1H-1,2,4-triazol-1-yl)methanone ID: ALA3787453
PubChem CID: 127033069
Max Phase: Preclinical
Molecular Formula: C24H24FN5O3
Molecular Weight: 449.49
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(N1CCC(N2C[C@H](c3ccc(F)cc3)[C@H]2c2ccc3c(c2)OCO3)CC1)n1cncn1
Standard InChI: InChI=1S/C24H24FN5O3/c25-18-4-1-16(2-5-18)20-12-29(23(20)17-3-6-21-22(11-17)33-15-32-21)19-7-9-28(10-8-19)24(31)30-14-26-13-27-30/h1-6,11,13-14,19-20,23H,7-10,12,15H2/t20-,23-/m1/s1
Standard InChI Key: IWSLFABPEBZJJD-NFBKMPQASA-N
Molfile:
RDKit 2D
33 38 0 0 0 0 0 0 0 0999 V2000
-3.9638 2.9172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4118 2.5255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0201 1.0775 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6168 1.4950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2004 4.2093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7374 4.4802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2375 5.8944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2124 7.0345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6871 6.7603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1870 5.3460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7510 -0.2332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2474 -1.6332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2167 -2.7779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.6928 -2.5108 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-8.1995 -1.0990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.2301 0.0457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8125 8.1659 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-8.6650 -3.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.2616 -4.7843 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-10.1415 -3.3848 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-11.2072 -4.4221 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-12.5260 -3.7074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.2538 -2.2323 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-10.7668 -2.0354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 1 1 0
5 6 2 0
6 23 1 0
22 7 1 0
7 8 2 0
8 5 1 0
4 5 1 1
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
1 9 1 6
15 16 1 0
15 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
3 15 1 0
12 21 1 0
22 23 2 0
23 24 1 0
24 25 1 0
25 26 1 0
26 22 1 0
18 27 1 0
27 28 2 0
27 29 1 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 449.49Molecular Weight (Monoisotopic): 449.1863AlogP: 3.42#Rotatable Bonds: 3Polar Surface Area: 72.72Molecular Species: NEUTRALHBA: 7HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.06CX LogP: 2.10CX LogD: 1.36Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.61Np Likeness Score: -0.80
References 1. Brindisi M, Maramai S, Gemma S, Brogi S, Grillo A, Di Cesare Mannelli L, Gabellieri E, Lamponi S, Saponara S, Gorelli B, Tedesco D, Bonfiglio T, Landry C, Jung KM, Armirotti A, Luongo L, Ligresti A, Piscitelli F, Bertucci C, Dehouck MP, Campiani G, Maione S, Ghelardini C, Pittaluga A, Piomelli D, Di Marzo V, Butini S.. (2016) Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain., 59 (6): [PMID:26888301 ] [10.1021/acs.jmedchem.5b01812 ]